|
1 Hikmet H, Basar T, Tanser S, et al. Are the site, diameter, and number of endometrial polyps related with symptomatology? Am J Obstet Gynecol, 2006, 194(3): 718–721.
|
|
2 Anastasiadis PG, Koutlaki NG, Skaphida PG, et al. Endometrial polyps: Prevalence, detection, and malignant potential in women with abnormal uterine bleeding. Eur J Gynaecol Oncol, 2000, 21(2)：180–183.
|
|
3 Hinckley MD, Milki AA. 1000 office–based hysteroscopies prior to in vitro fertilization: Feasibility and findings. J Soc Laparo Surg, 2004, 8(2)：103–107.
|
|
4 Taylor LJ, Jackson TL, Reid JG, et al. The differential expression of estrogen receptors, progesterone receptors, Bcl–2 and Ki67 in endometrial polyps. BJOG: Int J Obstet Gynaecol, 2003, 110(9)：794–798.
|
|
5 Belisario MS, Vassallo J, Andrade LA, et al. The expression of the hormone receptors in the endometrium and endometrial polyps in postmenopausal women and its relationship to body mass index. Maturitas, 2006, 53(1)：114–118.
|
|
6 McGurgan P, Taylor LJ, Duffy SR, et al. Are endometrial polyps from pre–menopausal women similar to post–menopausal women? An immunohistochemical comparison of endometrial polyps from pre– and post–menopausal women. Maturitas, 2006, 54(3): 277–284.
|
|
7 Ye H, Xu XR, Liu YK, et al. Study on the relationship between estrogen receptor β and etiology of human endometrial polyps. Chin J Obstet Gynecol, 2006, 41(12): 814–816.[叶红，许先蓉，刘幼昆，等．雌激素受体β与子宫内膜息肉发病关系的研究. 中华妇产科杂志，2006, 41(12): 814–816.]
|
|
8 Maia HJ, Pimentel K, Silva T, et al. Aromatase and cyclooxygenase–2 expression in endometrial polyps during the menstrual cycle. Gynecol Endocrinol, 2006, 22(4)：219–224.
|
|
9 Lubna P, Andrea N, Mini K, et al. Heterogeneity in endometrial expression of aromatase in polyp–bearing uteri. Hum Reprod, 2008, 23(1)：80–84.
|
|
10 Mylonas I, Makovitzky J, Fernow A, et al. Expression of the inhibin/activin subunits α (alpha), beta–A (betaA) and beta–B (betaB) in benign human endometrial polyps and tamoxifen–associated polyps. Arch Gynecol Obstet, 2005, 272(1): 59–66.
|
|
11 Hague S, Manek S, Oehler MK, et al. Tamoxifen induction of angiogenic factor expression in endometrium. Br J Cancer, 2002, 86(5): 761–767.
|
|
12 Coskun U, Gunel N，Sancak B, et al. Effect of tamoxifen on serum IL–18, vascular endothelial growth factor and nitric oxide activities in breast carcinoma patients. Clin Exp Immunol, 2004, 137: 546–551.
|
|
13 Inceboz US, Nese N, Uyar Y, et al. Hormone receptor expressions and proliferation markers in postmenopausal endometrial polyps. Gynecol Obstet Invest, 2006, 61(1): 24–28.
|
|
14 Nogueira AA, Almeida SA, Carvalho E, et al. Immunohistochemical expression of p63 in endometrial polyps: Evidence that a basal cell immunophenotype is maintained. Menopause, 2006, 13(5): 826–830.
|
|
15 d'Arailh AS, Michy T, Pioud R, et al. Uterine abnormalities in non menopausal women who received tamoxifen for breast cancer adjuvant therapy. Gynecol Obstet Fertil, 2007, 35(12): 1215–1219.
|
|
16 Altaner S, Gucer F, Tokatli F, et al. Expression of Bcl–2 and Ki–67 in tamoxifen–associated endometrial polyps: Comparison with postmenopausal polyps. Onkologie, 2006, 29(8–9): 376–380.
|
|
17 McGurgan P, Taylor LJ, Duffy SR, et al. Does tamoxifen therapy affect the hormone receptor expression and cell proliferation indices of endometrial polyps? An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to tamoxifen. Maturitas, 2006, 54(3): 252–259.
|
|
18 Bernd G, Annette K, Toralf R, et al. Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine–responsive breast cancer and tamoxifen–induced endometrial pathology. Clin Can Res, 2006, 12(4): 1245–1250.
|
|
19 Huang W. Current study and research of hormonal therapy in postmenopausal women. Chin J Obstet Gynecol Pediatr (Electron Ed), 2006，2(4)：184–187. [黄薇．绝经后激素治疗的研究现状. (J/CD). 中华妇幼临床医学杂志：电子版，2006，2(4)：184–187.]
|
|
20 Oguz S, Sargin A, Kelekci S, et al. The role of hormone replacement therapy in endometrial polyp formation. Maturitas, 2005, 50: 231–236.
|
|
21 Iatrakis G, Zervoudis S, Antoniou E, et al. Is dosage of hormone replacement therapy related with endometrial polyp formation? Eur J Gynaecol Oncol, 2006, 27(4): 393–394.
|